[go: up one dir, main page]

AU3006697A - Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines - Google Patents

Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines

Info

Publication number
AU3006697A
AU3006697A AU30066/97A AU3006697A AU3006697A AU 3006697 A AU3006697 A AU 3006697A AU 30066/97 A AU30066/97 A AU 30066/97A AU 3006697 A AU3006697 A AU 3006697A AU 3006697 A AU3006697 A AU 3006697A
Authority
AU
Australia
Prior art keywords
muramylpeptides
lipophile
chemokines
induction
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30066/97A
Inventor
David Fast
Gerald J. Vosika
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Soligenix Inc
Original Assignee
Endorex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorex Corp filed Critical Endorex Corp
Publication of AU3006697A publication Critical patent/AU3006697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30066/97A 1996-05-10 1997-05-09 Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines Abandoned AU3006697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1724896P 1996-05-10 1996-05-10
US60017248 1996-05-10
PCT/US1997/008146 WO1997043308A1 (en) 1996-05-10 1997-05-09 Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines

Publications (1)

Publication Number Publication Date
AU3006697A true AU3006697A (en) 1997-12-05

Family

ID=21781559

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30066/97A Abandoned AU3006697A (en) 1996-05-10 1997-05-09 Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines

Country Status (2)

Country Link
AU (1) AU3006697A (en)
WO (1) WO1997043308A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735411T2 (en) * 1996-10-09 2006-09-07 Symyx Technologies, Inc., Santa Clara INFRARED SPECTROSCOPY AND LIBRARY IMAGING
WO1999033787A1 (en) * 1997-12-26 1999-07-08 Kureha Chemical Industry Co., Ltd. Amino acid derivatives
FR2809106A1 (en) * 2000-05-17 2001-11-23 Istac New human Ro/SSA-like polypeptide, useful for treatment, prevention and diagnosis of e.g. autoimmune disease and viral infection, also related nucleic acid and antibodies
RU2379049C2 (en) * 2007-12-11 2010-01-20 Олег Витальевич Калюжин Drug for hiv-infection treatment
CA2719252C (en) * 2008-04-01 2016-01-19 Innate Therapeutics Limited Anti-infective agents comprising muramyl dipeptide microparticles and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564096B1 (en) * 1984-05-11 1988-02-19 Anvar LIPOPHILIC DERIVATIVES OF MURAMYLPEPTIDES HAVING MACROPHAGE ACTIVATION PROPERTIES, COMPOSITIONS CONTAINING THEM AND PROCESS FOR OBTAINING THE SAME
FR2724845B1 (en) * 1994-09-26 1997-01-17 Vacsyn Sa MURAMYL PEPTIDES COMPOSITIONS CAPABLE OF INHIBITING UP TO 100% REPLICATION OF AN ACQUIRED IMMUNO DEFICIENCY VIRUS, SUCH AS HIV
WO1996014744A1 (en) * 1994-11-14 1996-05-23 National Jewish Center For Immunology And Respiratory Medicine Protective effects of mutated superantigens

Also Published As

Publication number Publication date
WO1997043308A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
AU3629697A (en) Radio-frequency and microwave-assisted processing of materials
AU3742597A (en) Disposable undergarment waistband and method of forming same
AU663833B2 (en) Surgical and/or clinical apparatus
AU2214897A (en) Disposable surgical drape
AU1251197A (en) Treatment of liquors
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU7297998A (en) Bariatric treatment system and relating methods
AU4013495A (en) Chemokine-like proteins and methods of use
AU3006697A (en) Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
AU5674496A (en) Murine and human box-dependent myc-interacting protein (bin1 ) and uses therefor
AUPN911496A0 (en) Patient lifting aid
AU4229197A (en) Treatment of equine protozoal myeloencephalitis
AU3530395A (en) Treatment of viral infections
AU2814597A (en) Vaccines for treatment of lymphoma and leukemia
AU5654998A (en) Muteins of obese protein
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
EP0686401A3 (en) Living-tissue adhesive and blood coagulant
AU4897397A (en) Proteins of kaposi's sarcoma associated herpesvirus
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
AU4468597A (en) Improved surgical dressings and method of preparation
AU3650197A (en) Mutated antibody-dependent infection enhancing domains of hiv
AU5095996A (en) Interferon-gamma treatment of HLA-DR-associated immunodeficiency
AU3908397A (en) Mammalian and human fxi-t1
AU5802798A (en) Human oncogene induced secreted protein i